Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP and Chief Medical Officer
-
Stock Symbol
-
RARE on Nasdaq
Eric Crombez - trading volume in the past year for Ultragenyx Pharmaceutical Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
48.4K |
$2.11M |
$43.66 |
May 2, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
2.35K |
|
|
Mar 1, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.